Alkermes Plc: Sales Rise, Losses Fall, And The Pipeline Moves Forward

Alkermes (NASDAQ: ALKS), a biopharmaceutical company that specializes in extended-release drug delivery technology, reported third-quarter results on Nov. 2 and provided investors with an update on its pipeline. Let's dig in to see what happened with the company during the period.Image source: Getty Images.Continue reading

Topics:  alkermes nasdaq   alks    nov   images   pipeline   company   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News